Leyden Laboratories BV (Netherlands) ▲ Sign in to save

• A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration

  2024 Scientific Reports article Medicine Influenza Virus Research Studies Open access cited by 1 patent

  25

  citations
• The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

  2022 Frontiers in Virology article Medicine Influenza Virus Research Studies Open access cited by 1 patent

  18

  citations
• SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies

  2023 European Journal of Epidemiology article Mathematics COVID-19 epidemiological studies Open access

  17

  citations
• Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community

  2022 Infectious Diseases and Therapy article Medicine SARS-CoV-2 and COVID-19 Research Open access

  12

  citations
• Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection

  2025 Scientific Reports article Medicine Influenza Virus Research Studies Open access

  11

  citations
• Biological Aging for Risk Prediction of First-Ever Intracerebral Hemorrhage and Cerebral Infarction in Advanced Age

  2022 Journal of Stroke and Cerebrovascular Diseases article Medicine Intracerebral and Subarachnoid Hemorrhage Research Open access

  9

  citations
• Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaques

  2025 Immunity article Medicine Influenza Virus Research Studies Open access

  9

  citations
• Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114

  2026 Science Translational Medicine article Medicine Influenza Virus Research Studies

  4

  citations
• Preventing SARS-CoV-2 superspreading events with antiviral intranasal sprays

  2025 Journal of Theoretical Biology article Mathematics COVID-19 epidemiological studies Open access

  1

  citations
• A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study

  2026 Nature Communications article Medicine Influenza Virus Research Studies Open access

  1

  citations
• Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

  2023 Frontiers in Virology erratum Medicine Influenza Virus Research Studies Open access

  1

  citations
• EE241 Economic Burden of Influenza Hospitalization in High-Risk Patient Groups in the US

  2023 Value in Health conference-abstract Medicine Influenza Virus Research Studies Open access

  1

  citations
• Data dashboard to support meta-analyses on influenza vaccine effectiveness across regions, influenza seasons and outcomes

  2025 medRxiv preprint Medicine Influenza Virus Research Studies Open access

  0

  citations
• Programmable antibody-based chimeric entry receptors for sarbecoviruses

  2026 Communications Biology article Medicine SARS-CoV-2 and COVID-19 Research Open access

  0

  citations
• Intranasal administration of a pan-reactive influenza antibody reveals Fc-independent mode of protection 2259232

  2026 The Journal of Immunology article Medicine Influenza Virus Research Studies

  0

  citations

15 results